Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study
Richard H. Ko(Children's Hospital of Los Angeles), Mignon L. Loh(Seattle Children's Hospital), Phillip Barnette(Children's Hospital of Los Angeles), Elizabeth A. Raetz(NYU Langone Health), Elena Eckroth(Children's Hospital of Los Angeles), Clare J. Twist(Children's Hospital of Los Angeles), Paul S. Gaynon(University of Southern California), Richard Sposto(Children's Hospital of Los Angeles), Nita L. Seibel(National Cancer Institute), Bruce Bostrom(Children's Hospital of Los Angeles), Raymond J. Hutchinson(Children's Hospital of Los Angeles), Lingyun Ji(University of Southern California)
Cited by 276
Related Papers
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
|New England Journal of Medicine|1999|1.2k